Genoscience Pharma SAS
Records under this name other than patents Genoscience Pharma SAS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Genoscience Pharma SAS
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,987,302 | Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent Lapsed on the fee record Ended Mar 24, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 24, 2019 | From the USPTO record |
| US 8,575,195 | Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent Lapsed on the fee record Ended Nov 5, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2017 | From the USPTO record |